Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Paul Axisa

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Experimental Medicine|March 2, 2021
Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cellsLiliana E Lucca, Pierre-Paul Axisa, Benjamin Lu, et al.
Nature Immunology|March 18, 2022
Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cellsTomokazu S Sumida, Shai Dulberg, Jonas C Schupp, et al.
Science Translational Medicine|December 14, 2022
A multiple sclerosis-protective coding variant reveals an essential role for HDAC7 in regulatory T cellsPierre-Paul Axisa, Tomomi M Yoshida, Liliana E Lucca, et al.
Blood|June 14, 2024
NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myelomaEve Blanquart, Rüçhan Ekren, Bineta Rigaud, et al.
The Journal of Clinical Investigation|March 11, 2025
Transcriptomic profiling after B cell depletion reveals central and peripheral immune cell changes in multiple sclerosisJessica Wei, Jeonghyeon Moon, Yoshiaki Yasumizu, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Systems Analysis of Immune Changes after B-cell Depletion in Autoimmune Multiple SclerosisJessica Wei, Jeonghyeon Moon, Yoshiaki Yasumizu, et al.
Nature Genetics|May 13, 2024
Genetic mapping across autoimmune diseases reveals shared associations and mechanismsMatthew R Lincoln, Noah Connally, Pierre-Paul Axisa, et al.
Research Square|March 11, 2024
Circulating Tumor Reactive KIR+CD8+ T cells Suppress Anti-Tumor Immunity in Patients with MelanomaDavid Hafler, Benjamin Lu, Liliana Lucca, et al.
Immunity|July 1, 2023
TCR-independent CD137 (4-1BB) signaling promotes CD8<sup>+</sup>-exhausted T cell proliferation and terminal differentiationAndrea C Pichler, Nadège Carrié, Marine Cuisinier, et al.
Nature Immunology|November 28, 2024
Circulating tumor-reactive KIR<sup>+</sup>CD8<sup>+</sup> T cells suppress anti-tumor immunity in patients with melanomaBenjamin Y Lu, Liliana E Lucca, Wesley Lewis, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Experimental Medicine|March 2, 2021
Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cellsLiliana E Lucca, Pierre-Paul Axisa, Benjamin Lu, et al.
Nature Immunology|March 18, 2022
Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cellsTomokazu S Sumida, Shai Dulberg, Jonas C Schupp, et al.
Science Translational Medicine|December 14, 2022
A multiple sclerosis-protective coding variant reveals an essential role for HDAC7 in regulatory T cellsPierre-Paul Axisa, Tomomi M Yoshida, Liliana E Lucca, et al.
Blood|June 14, 2024
NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myelomaEve Blanquart, Rüçhan Ekren, Bineta Rigaud, et al.
The Journal of Clinical Investigation|March 11, 2025
Transcriptomic profiling after B cell depletion reveals central and peripheral immune cell changes in multiple sclerosisJessica Wei, Jeonghyeon Moon, Yoshiaki Yasumizu, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Systems Analysis of Immune Changes after B-cell Depletion in Autoimmune Multiple SclerosisJessica Wei, Jeonghyeon Moon, Yoshiaki Yasumizu, et al.
Nature Genetics|May 13, 2024
Genetic mapping across autoimmune diseases reveals shared associations and mechanismsMatthew R Lincoln, Noah Connally, Pierre-Paul Axisa, et al.
Research Square|March 11, 2024
Circulating Tumor Reactive KIR+CD8+ T cells Suppress Anti-Tumor Immunity in Patients with MelanomaDavid Hafler, Benjamin Lu, Liliana Lucca, et al.
Immunity|July 1, 2023
TCR-independent CD137 (4-1BB) signaling promotes CD8<sup>+</sup>-exhausted T cell proliferation and terminal differentiationAndrea C Pichler, Nadège Carrié, Marine Cuisinier, et al.
Nature Immunology|November 28, 2024
Circulating tumor-reactive KIR<sup>+</sup>CD8<sup>+</sup> T cells suppress anti-tumor immunity in patients with melanomaBenjamin Y Lu, Liliana E Lucca, Wesley Lewis, et al.
Pageof 3